Digoxin tablets have a market value of roughly $2.1 million for the 12 months ending December 2021, according to IQVIA. Aurobindo has received the Food and Drug Administration's clearance for Digoxin ...
A randomized trial shows no significant difference in the primary endpoint of quality of life at 6 months between treatment with digoxin vs the beta-blocker bisoprolol (Zebeta) in patients with atrial ...
Treatment of advanced non-small cell lung cancer (NSCLC) with a biweekly schedule of irinotecan (I), paclitaxel, and cisplatinum (P): A phase II study No significant financial relationships to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback